Search research articles
Contact Us
Filters
Showing results (321-330 of 372) with videos related to
Page
of 38
Sort By:
Gut
|
August 4, 2012
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B
Pietro Lampertico, Mauro Viganò, Giovan Giuseppe Di Costanzo, et al.
Journal of Hepatology
|
January 17, 2012
Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a
Vincent Rijckborst, Bettina E Hansen, Peter Ferenci, et al.
Alimentary Pharmacology & Therapeutics
|
March 2, 2022
Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment
Mark Sulkowski, Laura E Telep, Massimo Colombo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 1, 2013
Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound
Marzia Galassi, Massimo Iavarone, Sandro Rossi, et al.
Seminars in Liver Disease
|
July 10, 2018
The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations
Jeffrey V Lazarus, Kelly Safreed-Harmon, Mark R Thursz, et al.
Journal of Viral Hepatitis
|
January 17, 2025
DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy
Amit G Singal, K Rajender Reddy, Massimo Colombo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
January 25, 2021
Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response
Zobair M Younossi, Andrei Racila, Andrew Muir, et al.
Hepatology Communications
|
March 8, 2021
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC
Roniel Cabrera, Amit G Singal, Massimo Colombo, et al.
The New England Journal of Medicine
|
October 12, 2017
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
Edward Gane, Eric Lawitz, David Pugatch, et al.
Journal of Hepatology
|
December 3, 2013
Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®)
Thierry Poynard, Julien Vergniol, Yen Ngo, et al.
Page
of 38
Search research articles
Search
Showing results (321-330 of 372) with videos related to
Sort By:
Page
of 38
Gut
|
August 4, 2012
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B
Pietro Lampertico, Mauro Viganò, Giovan Giuseppe Di Costanzo, et al.
Journal of Hepatology
|
January 17, 2012
Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a
Vincent Rijckborst, Bettina E Hansen, Peter Ferenci, et al.
Alimentary Pharmacology & Therapeutics
|
March 2, 2022
Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment
Mark Sulkowski, Laura E Telep, Massimo Colombo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 1, 2013
Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound
Marzia Galassi, Massimo Iavarone, Sandro Rossi, et al.
Seminars in Liver Disease
|
July 10, 2018
The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations
Jeffrey V Lazarus, Kelly Safreed-Harmon, Mark R Thursz, et al.
Journal of Viral Hepatitis
|
January 17, 2025
DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy
Amit G Singal, K Rajender Reddy, Massimo Colombo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
January 25, 2021
Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response
Zobair M Younossi, Andrei Racila, Andrew Muir, et al.
Hepatology Communications
|
March 8, 2021
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC
Roniel Cabrera, Amit G Singal, Massimo Colombo, et al.
The New England Journal of Medicine
|
October 12, 2017
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
Edward Gane, Eric Lawitz, David Pugatch, et al.
Journal of Hepatology
|
December 3, 2013
Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®)
Thierry Poynard, Julien Vergniol, Yen Ngo, et al.
Page
of 38